{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:58:04Z","timestamp":1776995884967,"version":"3.51.4"},"reference-count":117,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1080\/08916930500285857","type":"journal-article","created":{"date-parts":[[2005,12,21]],"date-time":"2005-12-21T20:44:16Z","timestamp":1135197856000},"page":"507-518","source":"Crossref","is-referenced-by-count":107,"title":["RETRACTED: Drug-induced lupus erythematosus"],"prefix":"10.1080","volume":"38","author":[{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Capsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Capsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Capsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Capsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1056\/NEJM198806023182209","volume":"318","author":"Hess E","year":"1988","unstructured":"Hess, E. (1988) Drug-related lupus <i>N Engl J Med<\/i>, 318, pp. 1460 - 1462.","journal-title":"N Engl J Med"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0889-857X(21)00226-X","volume":"20","author":"Yung RL","year":"1994","unstructured":"Yung, RL and ChB, MB and Richardson, BC. (1994) Drug-induced lupus <i>Rheum Dis Clin N Am<\/i>, 20, pp. 61 - 86.","journal-title":"Rheum Dis Clin N Am"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI119356","volume":"99","author":"Kretz-Rommel A","year":"1997","unstructured":"Kretz-Rommel, A and Duncan, SR and Rubin, RL. (1997) Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus <i>J Clin Investig<\/i>, 99, pp. 1888 - 1896.","journal-title":"J Clin Investig"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1567-5769(01)00046-7","volume":"1","author":"Rider V","year":"2001","unstructured":"Rider, V and Abdou, NI. (2001) Gender differences in autoimmunity: Molecular basis for estrogen effects in systemic lupus erythematosus <i>Int Immunopharmacol<\/i>, 1, pp. 1009 - 1024.","journal-title":"Int Immunopharmacol"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.167.4.1886","volume":"167","author":"Grimaldi CM","year":"2001","unstructured":"Grimaldi, CM and Michael, DJ and Diamond, B. (2001) Cutting edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus <i>J Immunol<\/i>, 167, pp. 1886 - 1890.","journal-title":"J Immunol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1471-4906(02)02204-4","volume":"23","author":"Vidaver R","year":"2002","unstructured":"Vidaver, R. (2002) Molecular and clinical evidence of the role of estrogen in lupus <i>Trends Immunol<\/i>, 23, pp. 229 - 230.","journal-title":"Trends Immunol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","volume":"19","author":"Feldmann M","year":"2001","unstructured":"Feldmann, M and Maini, RN. (2001) Anti-TNF therapy of rheumatoid arthritis: What have we learned? <i>Annu Rev Immunol<\/i>, 19, pp. 163 - 196.","journal-title":"Annu Rev Immunol"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","volume":"167","author":"Via CS","year":"2001","unstructured":"Via, CS and Shustov, A and Rus, V and Lang, T and Nguyen, P and Finkelman, FD. (2001) In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL <i>J Immunol<\/i>, 167, pp. 6821 - 6826.","journal-title":"J Immunol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","volume":"266","author":"Jiang X","year":"1994","unstructured":"Jiang, X and Khursigara, G and Rubin, RL. (1994) Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils <i>Science<\/i>, 266, pp. 810 - 813.","journal-title":"Science"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1126\/science.7725110","volume":"268","author":"von Schmiedeberg S","year":"1995","unstructured":"von Schmiedeberg, S and Goebel, C and Gleichmann, E and Uetrecht, J. (1995) Neutrophils and drug metabolism <i>Science<\/i>, 268, pp. 585 - 586.","journal-title":"Science"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/73152","volume":"6","author":"Kretz-Rommel A","year":"2000","unstructured":"Kretz-Rommel, A and Rubin, RL. (2000) Disruption of positive selection of thymocytes causes autoimmunity <i>Nat Med<\/i>, 6, pp. 298 - 305.","journal-title":"Nat Med"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/73101","volume":"6","author":"Datta SK","year":"2000","unstructured":"Datta, SK. (2000) Positive selection for autoimmunity <i>Nat Med<\/i>, 6, pp. 259 - 261.","journal-title":"Nat Med"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.162.2.813","volume":"162","author":"Rubin RL","year":"1999","unstructured":"Rubin, RL and Kretz-Rommel, A. (1999) Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus <i>J Immunol<\/i>, 162, pp. 813 - 820.","journal-title":"J Immunol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrg887","volume":"3","author":"Li E","year":"2002","unstructured":"Li, E. (2002) Chromatin modification and epigenetic reprogramming in mammalian development <i>Nat Rev Genet<\/i>, 3, pp. 662 - 673.","journal-title":"Nat Rev Genet"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/art.10234","volume":"46","author":"Lu Q","year":"2002","unstructured":"Lu, Q and Kaplan, M and Ray, D and Ray, D and Zacharek, S and Gutsch, D and Richardson, B. (2002) Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus <i>Arthritis Rheum<\/i>, 46, pp. 1282 - 1291.","journal-title":"Arthritis Rheum"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1172\/JCI118743","volume":"97","author":"Yung R","year":"1996","unstructured":"Yung, R and Powers, D and Johnson, K and (1996) Mechanisms of drug-induced lupus II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngenic mice <i>Clin Investig<\/i>, 97, pp. 2866 - 2871.","journal-title":"Clin Investig"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.154.6.3025","volume":"154","author":"Yung RL","year":"1995","unstructured":"Yung, RL and Quddus, J and Chrisp, CE and Johnson, KJ and Richardson, BC. (1995) Mechanism of drug-induced lupus I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo <i>J Immunol<\/i>, 154, pp. 3025 - 3035.","journal-title":"J Immunol"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/art.1780400811","volume":"40","author":"Yung R","year":"1997","unstructured":"Yung, R and Chang, S and Hemati, N and Johnson, K and Richardson, B. (1997) Mechanisms of drug-induced lupus IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo <i>Arthritis Rheum<\/i>, 40, pp. 1436 - 1443.","journal-title":"Arthritis Rheum"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1517\/14656566.2.10.1623","volume":"10","author":"di Fazano CS","year":"2001","unstructured":"di Fazano, CS and Bertin, P. (2001) The pharmacological management of drug-induced rheumatic disorders <i>Expert Opin Pharmacother<\/i>, 10, pp. 1623 - 1631.","journal-title":"Expert Opin Pharmacother"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1172\/JCI115353","volume":"88","author":"Burlingame RW","year":"1991","unstructured":"Burlingame, RW and Rubin, RL. (1991) Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin <i>J Clin Investig<\/i>, 88, pp. 680 - 690.","journal-title":"J Clin Investig"},{"key":"E00021","first-page":"118","volume":"13","author":"Rubin RL","year":"1987","unstructured":"Rubin, RL and Waga, S. (1987) Antihistone antibodies in systemic lupus erythematosus <i>J Rheumatol<\/i>, 13, pp. 118 - 126.","journal-title":"J Rheumatol"},{"key":"E00022","first-page":"147","volume":"55","author":"Atzeni F","year":"2003","unstructured":"Atzeni, F and Marrazza, MG and Sarzi-Puttini, P and Carrabba, M. (2003) Drug-induced lupus erythematosus <i>Reumatismo<\/i>, 55, pp. 147 - 154.","journal-title":"Reumatismo"},{"key":"E00023","first-page":"1","volume":"4","author":"Weinstein A","year":"1980","unstructured":"Weinstein, A. (1980) Drug-induced systemic lupus erythematosus <i>Prog Clin Immunol<\/i>, 4, pp. 1 - 21.","journal-title":"Prog Clin Immunol"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/bmj.284.6320.936","volume":"284","author":"Mansilla-Tinoco R","year":"1982","unstructured":"Mansilla-Tinoco, R and Harland, SJ and Ryan, PJ and Bernstein, RM and Dollery, CT and Hughes, GR and Bulpitt, CJ and Morgan, A and Jones, JM. (1982) Hydralazine, antinuclear antibodies, and the lupus syndrome <i>BMJ<\/i>, 284, pp. 936 - 939.","journal-title":"BMJ"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/bmj.289.6442.410","volume":"289","author":"Cameron HA","year":"1984","unstructured":"Cameron, HA and Ramsay, LE. (1984) The lupus syndrome induced by hydralazine: A common complication with low dose treatment <i>BMJ<\/i>, 289, pp. 410 - 412.","journal-title":"BMJ"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.1780250408","volume":"25","author":"Gioud M","year":"1982","unstructured":"Gioud, M and Kaci, MA and Monier, JC. (1982) Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool <i>Arthritis Rheum<\/i>, 25, pp. 407 - 413.","journal-title":"Arthritis Rheum"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/anr.1780321020","volume":"32","author":"Cohen WG","year":"1989","unstructured":"Cohen, WG and Webb, J. (1989) Antihistone antibodies in rheumatoid arthritis and Felty's syndrome <i>Arthritis Rheum<\/i>, 32, pp. 1319 - 1324.","journal-title":"Arthritis Rheum"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/j.2326-5205.1989.tb00025.x","volume":"32","author":"Malleson P","year":"1989","unstructured":"Malleson, P and Petty, RE and Fung, M and Candido, EP. (1989) Reactivity of antinuclear antibodies with histones and other antigens in juvenile rheumatoid arthritis <i>Arthritis Rheum<\/i>, 32, pp. 919 - 923.","journal-title":"Arthritis Rheum"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/art.1780290106","volume":"29","author":"Molden DP","year":"1986","unstructured":"Molden, DP and Klippe, GL and Peebles, CL and Rubin, RL and Nakamura, RM and Tan, EM. (1986) IgM-anti-histone H-3 antibody associated with undifferentiated rheumatic disease syndromes <i>Arthritis Rheum<\/i>, 29, pp. 39 - 46.","journal-title":"Arthritis Rheum"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4049\/jimmunol.138.2.446","volume":"138","author":"Portanova JP","year":"1987","unstructured":"Portanova, JP and Arndt, RE and Tan, EM and Kotzin, BL. (1987) Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions <i>J Immunol<\/i>, 138, pp. 446 - 451.","journal-title":"J Immunol"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0090-1229(85)90038-8","volume":"36","author":"Rubin RL","year":"1985","unstructured":"Rubin, RL and McNally, EM and Nusinow, SR and Robinson, CA and Tan, EM. (1985) IgG antibodies to the histone complex H2A\u2013H2B characterize procainamide-induced lupus <i>Clin Immunol Immunopathol<\/i>, 36, pp. 49 - 59.","journal-title":"Clin Immunol Immunopathol"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/ard.53.6.403","volume":"53","author":"Federmann M","year":"1994","unstructured":"Federmann, M and Morell, B and Graetz, G and Wyss, M and Elsner, P and von Thiessen, R and Wuthrich, B and Grob, D. (1994) Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus <i>Ann Rheum Dis<\/i>, 53, pp. 403 - 405.","journal-title":"Ann Rheum Dis"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(08)60777-4","volume":"49","author":"McNeil HP","year":"1991","unstructured":"McNeil, HP and Chesterman, CN and Krilis, SA. (1991) Immunology and clinical importance of antiphospholipid antibodies <i>Adv Immunol<\/i>, 49, pp. 193 - 280.","journal-title":"Adv Immunol"},{"key":"E00034","first-page":"p11","volume":"2","author":"Kauffman CL","year":"2001","unstructured":"Kauffman, CL and Sabbagh, AK. (2001) Lupus erythematosus, drug-induced <i>Med J<\/i>, 2, pp. p11.","journal-title":"Med J"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00045391-200203000-00012","volume":"9","author":"Siddiqui MA","year":"2002","unstructured":"Siddiqui, MA and Khan, IA. (2002) Isoniazid-induced lupus erythematosus presenting with cardiac tamponade <i>Am J Ther<\/i>, 9, pp. 163 - 165.","journal-title":"Am J Ther"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1378\/chest.117.2.597","volume":"117","author":"Verma SP","year":"2000","unstructured":"Verma, SP and Yunis, N and Lekos, A and Crausman, RS. (2000) Carbamazepine-induced systemic lupus erythematosus presenting as cardiac tamponade <i>Chest<\/i>, 117, pp. 597 - 598.","journal-title":"Chest"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1067\/mjd.2001.116583","volume":"45","author":"Callen JP","year":"2001","unstructured":"Callen, JP. (2001) Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized <i>J Am Acad Dermatol<\/i>, 45, pp. 315 - 316.","journal-title":"J Am Acad Dermatol"},{"key":"E00038","first-page":"135","volume":"26","author":"Hosftra A","year":"1994","unstructured":"Hosftra, A. (1994) Metabolism of hydralazine: Relevance to drug-induced lupus <i>Drug Metab Rev<\/i>, 26, pp. 135 - 138.","journal-title":"Drug Metab Rev"},{"key":"E00039","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","volume":"24","author":"Batchelor JR","year":"1980","unstructured":"Batchelor, JR and Welsh, KI and Tinoco, RM and Dollery, CT and Hughes, GR and Benestein, R. (1980) Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility <i>Lancet<\/i>, 24, pp. 1107 - 1109.","journal-title":"Lancet"},{"key":"E00040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/096032719401300810","volume":"13","author":"Torffvit O","year":"1994","unstructured":"Torffvit, O and Thysell, H and Nassberger, L. (1994) Occurrence of autoantibodies direct against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis <i>Hum Exp Toxicol<\/i>, 13, pp. 563 - 567.","journal-title":"Hum Exp Toxicol"},{"key":"E00041","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/03009749409103062","volume":"23","author":"Nasseberger L","year":"1994","unstructured":"Nasseberger, L and Hultquist, U and Sturfelt, G. (1994) Occurrence of anti-lactoferrin antibodies in patients with systemic lupus, hydralazine-induced lupus, and rheumatoid arthritis <i>Scand J Rheumatol<\/i>, 23, pp. 206 - 210.","journal-title":"Scand J Rheumatol"},{"key":"E00042","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0190-9622(84)80011-0","volume":"10","author":"Peterson LL","year":"1984","unstructured":"Peterson, LL. (1984) Hydralazine-induced systemic lupus erythematosus presenting as pyoderma gangrenosum-like ulcers <i>J Am Acad Dermatol<\/i>, 10, pp. 379 - 384.","journal-title":"J Am Acad Dermatol"},{"key":"E00043","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJM196212272672608","volume":"267","author":"Ladd AT","year":"1962","unstructured":"Ladd, AT. (1962) Procainamide-induced lupus erythematosus <i>N Engl J Med<\/i>, 267, pp. 1357 - 1358.","journal-title":"N Engl J Med"},{"key":"E00044","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0049-0172(75)90024-4","volume":"5","author":"Lee SL","year":"1975","unstructured":"Lee, SL and Chase, PH. (1975) Drug-induced systemic lupus erythematosus: A critical review <i>Semin Arthritis Rheum<\/i>, 5, pp. 83 - 103.","journal-title":"Semin Arthritis Rheum"},{"key":"E00045","first-page":"134","volume":"1","author":"Uretrech JP","year":"1988","unstructured":"Uretrech, JP. (1988) Mechanism of drug-induced lupus <i>Chem Res Toxicol<\/i>, 1, pp. 134 - 143.","journal-title":"Chem Res Toxicol"},{"key":"E00046","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.154.5.2483","volume":"154","author":"Rubin RL","year":"1995","unstructured":"Rubin, RL and Burlingame, RW and Arnott, JE and Totoritis, MC and McNally, EM and Johnson, D. (1995) IgG but not other classes of anti-(H2A\u2013H2B)-DNA is an early sign of procainamide-induced lupus <i>J Immunol<\/i>, 154, pp. 2483 - 2493.","journal-title":"J Immunol"},{"key":"E00047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00005792-196905000-00002","volume":"48","author":"Dubois EL","year":"1969","unstructured":"Dubois, EL. (1969) Procainamide induction of a systemic lupus-erythematosus-like syndrome <i>Medicine<\/i>, 48, pp. 217 - 228.","journal-title":"Medicine"},{"key":"E00048","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.2169\/naika.84.1736","volume":"84","author":"Muramatsu M","year":"1995","unstructured":"Muramatsu, M and Nakajiama, M and Mori, M and Sobashima, H and Sand, H and Katao, K. (1995) A case of primary antiphospholipid antibody syndrome associated with procainamide-induced systemic lupus erythematosus <i>Nippon NaiKa Gakkai Zasshi<\/i>, 84, pp. 1736 - 1738.","journal-title":"Nippon NaiKa Gakkai Zasshi"},{"key":"E00049","doi-asserted-by":"crossref","first-page":"650","DOI":"10.7326\/0003-4819-88-5-650","volume":"88","author":"Rothfield NF","year":"1978","unstructured":"Rothfield, NF and Bierer, WF and Oberg, KE. (1978) Isoniazid induction of antinuclear antibodies. A prospective study <i>Ann Int Med<\/i>, 88, pp. 650 - 652.","journal-title":"Ann Int Med"},{"key":"E00050","first-page":"1124","volume":"76","author":"Perry HMJr","year":"1970","unstructured":"Perry, HMJr and Tan, EM and Carmody, S and Sakamoto, A. (1970) Relationship of acetyl-trasferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine <i>J Lab Clin Med<\/i>, 76, pp. 1124 - 1125.","journal-title":"J Lab Clin Med"},{"key":"E00051","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archinte.1967.00300030063012","volume":"120","author":"Sherman JD","year":"1967","unstructured":"Sherman, JD and Love, DE and Harrington, JF. (1967) Anemia, positive lupus and rheumatoid arthritis factors with methyldopa <i>Arch Intern Med<\/i>, 120, pp. 321 - 326.","journal-title":"Arch Intern Med"},{"key":"E00052","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2169\/naika.84.2069","volume":"84","author":"Sakurai Y","year":"1995","unstructured":"Sakurai, Y and Kurihara, R and Takeuchi, M and Suga, S and Owada, K and Yoneshima, H. (1995) A case of SLE-like syndrome and severe haemolytic anaemia caused by methyldopa <i>Nippon NaiKa Gakkai Zasshi<\/i>, 84, pp. 2069 - 2071.","journal-title":"Nippon NaiKa Gakkai Zasshi"},{"key":"E00053","first-page":"543","volume":"15","author":"Alarcon-Segovia D","year":"1973","unstructured":"Alarcon-Segovia, D and Fishbein, E and Cetina, JA and Raya, RJ and Barrera, E. (1973) Antigenic specificity of chlorpromazine-induced antinuclear antibodies <i>Clin Exp Immunol<\/i>, 15, pp. 543 - 548.","journal-title":"Clin Exp Immunol"},{"key":"E00054","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ajh.2830270408","volume":"27","author":"Canoso RT","year":"1988","unstructured":"Canoso, RT and De Oliveira, RM. (1988) Clorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosis <i>Am J Hematol<\/i>, 27, pp. 272 - 275.","journal-title":"Am J Hematol"},{"key":"E00055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0049-0172(95)80003-4","volume":"24","author":"Alloway JA","year":"1995","unstructured":"Alloway, JA and Salata, MP. (1995) Quinidine-induced rheumatic syndromes <i>Semin Arthritis Rheum<\/i>, 24, pp. 315 - 322.","journal-title":"Semin Arthritis Rheum"},{"key":"E00056","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archinte.159.5.493","volume":"159","author":"Sturkenboom MC","year":"1999","unstructured":"Sturkenboom, MC and Meier, CR and Jick, H and Stricker, BH. (1999) Minocycline and lupus-like syndrome in acne patients <i>Arch Intern Med<\/i>, 159(159), pp. 493 - 497.","journal-title":"Arch Intern Med"},{"key":"E00057","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mjd.2001.112218","volume":"44","author":"Schaffer JV","year":"2001","unstructured":"Schaffer, JV and Davidson, DM and McNiff, JM and Bolognia, JL. (2001) Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris <i>J Am Acad Dermatol<\/i>, 44, pp. 198 - 206.","journal-title":"J Am Acad Dermatol"},{"key":"E00058","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/40.3.329","volume":"40","author":"Lawson TM","year":"2001","unstructured":"Lawson, TM and Amos, N and Bulgen, D and Williams, BD. (2001) Minocycline-induced lupus: Clinical features and response to rechallenge <i>Rheumatology (Oxford)<\/i>, 40, pp. 329 - 335.","journal-title":"Rheumatology (Oxford)"},{"key":"E00059","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-9343(98)00325-8","volume":"105","author":"Elkayam O","year":"1998","unstructured":"Elkayam, O and Levartovsky, D and Brautbar, C and Yaron, M and Burke, M and Vardinon, N and Caspi, D. (1998) Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena <i>Am J Med<\/i>, 105, pp. 484 - 487.","journal-title":"Am J Med"},{"key":"E00060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.55.10.769","volume":"55","author":"Elkayam O","year":"1996","unstructured":"Elkayam, O and Yaron, M and Caspi, D. (1996) Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA <i>Ann Rheum Dis<\/i>, 55, pp. 769 - 771.","journal-title":"Ann Rheum Dis"},{"key":"E00061","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.312.7024.169","volume":"312","author":"Gough A","year":"1996","unstructured":"Gough, A and Chapman, S and Wagstaff, K and Emery, P and Elias, E. (1996) Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome <i>BMJ<\/i>, 312, pp. 169 - 172.","journal-title":"BMJ"},{"key":"E00062","first-page":"104","volume":"22","author":"Khattak FH","year":"1993","unstructured":"Khattak, FH and Morris, IM and Mattingly, PC. (1993) Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis <i>Br J Rheumatol<\/i>, 22, pp. 104.","journal-title":"Br J Rheumatol"},{"key":"E00063","first-page":"2157","volume":"21","author":"Bray VJ","year":"1994","unstructured":"Bray, VJ and West, SG and Schultz, KT and Boumpas, DT and Rubin, RL. (1994) Antihistone antibody profile in sulfasalazine-induce lupus <i>J Rheumatol<\/i>, 21, pp. 2157 - 2158.","journal-title":"J Rheumatol"},{"key":"E00064","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/03009749309095143","volume":"22","author":"Mielke H","year":"1993","unstructured":"Mielke, H and Wildhagen, K and Mau, W and Ziedler, H. (1993) Follow-up of patients with double-stranded DNA antibodies induced by sulfasalazine during the treatment of inflammatory rheumatic diseases <i>Scand J Rheumatol<\/i>, 22, pp. 229 - 301.","journal-title":"Scand J Rheumatol"},{"key":"E00065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00002826-198904000-00005","volume":"12","author":"Dvory VE","year":"1989","unstructured":"Dvory, VE and Just, I and Korezym, AD. (1989) Carbamazepine-induced systemic lupus erythematosus <i>Clin Neuropharmacol<\/i>, 12, pp. 115 - 118.","journal-title":"Clin Neuropharmacol"},{"key":"E00066","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/096120339300200312","volume":"2","author":"Ansell BM","year":"1992","unstructured":"Ansell, BM. (1992) Drug-induced systemic lupus erythematosus in a nine-year old boy <i>Lupus<\/i>, 2, pp. 193 - 194.","journal-title":"Lupus"},{"key":"E00067","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1346-8138.1994.tb01783.x","volume":"21","author":"Sato-Matsumura KC","year":"1994","unstructured":"Sato-Matsumura, KC and Koizumi, H and Mazumura, T and Takahashi, T and Adachi, K and Ohkawara, A. (1994) Lupus erythematosus-like syndrome induced by thimazole and propylthiouracil <i>J Dermatol<\/i>, 21, pp. 501 - 507.","journal-title":"J Dermatol"},{"key":"E00068","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2230.1995.tb01340.x","volume":"20","author":"Kawachi Y","year":"1995","unstructured":"Kawachi, Y and Nukaga, H and Hoshino, N and Iwata, M and Otsuka, F. (1995) ANCA-associated vasculitis and lupus-like syndrome caused by methymazole <i>Clin Exp Dermatol<\/i>, 20, pp. 345 - 347.","journal-title":"Clin Exp Dermatol"},{"key":"E00069","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-4362.1990.tb03471.x","volume":"29","author":"Tsankov N","year":"1990","unstructured":"Tsankov, N and Lazarova, A and Vasileva, S and Obreshkova, EV. (1990) Lupus erythematosus-like syndrome eruption due to d-penicillamine in progressive systemic sclerosis <i>Int J Dermatol<\/i>, 29, pp. 571 - 574.","journal-title":"Int J Dermatol"},{"key":"E00070","first-page":"155","volume":"8","author":"Walshe J","year":"1981","unstructured":"Walshe, J. (1981) Penicillamine and the SLE syndrome <i>J Rheumatol<\/i>, 8, pp. 155 - 160.","journal-title":"J Rheumatol"},{"key":"E00071","first-page":"977","volume":"19","author":"Zamber RW","year":"1992","unstructured":"Zamber, RW and Starkebaum, G and Rubin, RL and Martens, HF and Wener, MH. (1992) Drug-induced systemic lupus erythematosus due to ophthalmic timolol <i>J Rheumatol<\/i>, 19, pp. 977 - 979.","journal-title":"J Rheumatol"},{"key":"E00072","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0190-9622(08)80652-4","volume":"28","author":"Goodrich A","year":"1993","unstructured":"Goodrich, A and Kohn, S. (1993) Hydrochlorthiazide-induced lupus erythematosus. A new variant? <i>J Am Acad Dermatol<\/i>, 28, pp. 1001 - 1002.","journal-title":"J Am Acad Dermatol"},{"key":"E00073","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0190-9622(88)70005-5","volume":"18","author":"Darken M","year":"1988","unstructured":"Darken, M and McBurney, E. (1988) Subacute cutaneous-like drug eruption due combination diuretic hydrochlorthiazide and triamterene <i>J Am Acad Dermatol<\/i>, 18, pp. 38 - 42.","journal-title":"J Am Acad Dermatol"},{"key":"E00074","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1528-1157.1994.tb02927.x","volume":"35","author":"Bleck TP","year":"1994","unstructured":"Bleck, TP and Smith, MC. (1994) Possible induction of systemic lupus erythematosus by valproate <i>Epilepsia<\/i>, 35, pp. 162 - 163.","journal-title":"Epilepsia"},{"key":"E00075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","volume":"107","author":"Raanani P","year":"2002","unstructured":"Raanani, P and Ben-Bassat, I. (2002) Immune-mediated complications during interferon therapy in hematological patients <i>Acta Haematol<\/i>, 107, pp. 133 - 144.","journal-title":"Acta Haematol"},{"key":"E00076","first-page":"1621","volume":"18","author":"Graninger WB","year":"1991","unstructured":"Graninger, WB and Hassfeld, W and Pesau, BB and Machold, KP and Zielinski, CC and Smolen, JS. (1991) Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis <i>J Rheumatol<\/i>, 18, pp. 1621 - 1622.","journal-title":"J Rheumatol"},{"key":"E00077","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(05)79887-1","volume":"352","author":"Nousari HC","year":"1998","unstructured":"Nousari, HC and Kimyai-Asadi, A and Tausk, FA. (1998) Subacute cutaneous lupus erythematosus associated with interferon beta-1a <i>Lancet<\/i>, 352, pp. 1825 - 1826.","journal-title":"Lancet"},{"key":"E00078","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000236130","volume":"97","author":"Gonzalo JA","year":"1992","unstructured":"Gonzalo, JA and Cuende, E and ales-Martinez, JE and Martinez, AC and Kroemer, G. (1992) Interleukin-2: A possible trigger of autoimmunity <i>Int Arch Allergy Immunol<\/i>, 97, pp. 251 - 257.","journal-title":"Int Arch Allergy Immunol"},{"key":"E00079","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9343(92)90789-E","volume":"92","author":"Massarotti LM","year":"1992","unstructured":"Massarotti, LM and Lui, NY and Mier, J and Atkins, MB. (1992) Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy <i>Am J Med<\/i>, 92, pp. 693 - 697.","journal-title":"Am J Med"},{"key":"E00080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/096120339400300605","volume":"3","author":"Fritzler MJ","year":"1994","unstructured":"Fritzler, MJ. (1994) Drugs recently associated with lupus syndromes <i>Lupus<\/i>, 3, pp. 455 - 459.","journal-title":"Lupus"},{"key":"E00081","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(02)07718-8","volume":"359","author":"Day R","year":"2002","unstructured":"Day, R. (2002) Adverse reactions to TNF-\u03b1 inhibitors in rheumatoid arthritis <i>Lancet<\/i>, 359, pp. 540 - 541.","journal-title":"Lancet"},{"key":"E00082","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","volume":"359","author":"Shakoor N","year":"2002","unstructured":"Shakoor, N and Michalska, M and Harris, CA and Block, JA. (2002) Drug-induced systemic lupus erythematosus associated with etanercept therapy <i>Lancet<\/i>, 359, pp. 579 - 580.","journal-title":"Lancet"},{"key":"E00083","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(02)09800-8","volume":"360","author":"Mohan AK","year":"2002","unstructured":"Mohan, AK and Edwards, ET and Cote, TR and Siegel, JN and Braun, MM. (2002) Drug-induced systemic lupus erythematosus and TNF-alpha blockers <i>Lancet<\/i>, 360, pp. 646.","journal-title":"Lancet"},{"key":"E00084","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/40.11.1317","volume":"40","author":"Bleumink GS","year":"2001","unstructured":"Bleumink, GS and ter Borg, EJ and Ramselaar, CG and Ramselaar, CG and Ch Stricker, BH. (2001) Etanercept-induced subacute cutaneous lupus erythematosus <i>Rheumatology<\/i>, 40, pp. 1317 - 1319.","journal-title":"Rheumatology"},{"key":"E00085","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1590-8658(03)00448-1","volume":"35","author":"Sarzi-Puttini P","year":"2003","unstructured":"Sarzi-Puttini, P and Ardizzone, S and Manzionna, G and Atzeni, F and Colombo, E and Antivalle, M and Carrabba, M and Bianchi-Porro, G. (2003) Infliximab-induced lupus in Crohn's disease: A case report <i>Dig Liv Dis<\/i>, 35, pp. 814 - 817.","journal-title":"Dig Liv Dis"},{"key":"E00086","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/archinte.162.19.2240","volume":"162","author":"Spiera RF","year":"2002","unstructured":"Spiera, RF and Bermman, RS and Wemer, AJ and Spiera, H. (2002) Ticlopidine-induced lupus: A report of a 4 cases <i>Arch Intern Med<\/i>, 162, pp. 2240 - 2243.","journal-title":"Arch Intern Med"},{"key":"E00087","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archinte.162.7.834","volume":"162","author":"Sheikhadeh A","year":"2002","unstructured":"Sheikhadeh, A and Schafer, U and Schnabel, A. (2002) Drug-induced lupus erythematosus by amiodarone <i>Arch Intern Med<\/i>, 162, pp. 834 - 836.","journal-title":"Arch Intern Med"},{"key":"E00088","first-page":"695","volume":"11","author":"Bertin P","year":"1993","unstructured":"Bertin, P and Kamdem, J and Bonnet, C and arnaud, M and treves, R. (1993) Captopril induced lupus <i>Clin Exp Rheumatol<\/i>, 11, pp. 695.","journal-title":"Clin Exp Rheumatol"},{"key":"E00089","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0140-6736(90)91717-O","volume":"336","author":"Schwartz D","year":"1990","unstructured":"Schwartz, D and Pines, A and Averbuch, M and Levo, Y. (1990) Enalapril-induced antinuclear antibodies <i>Lancet<\/i>, 336, pp. 187.","journal-title":"Lancet"},{"key":"E00090","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/00007611-200111000-00017","volume":"94","author":"Carter JD","year":"2001","unstructured":"Carter, JD and Valeriano-Marcet, J and Kanik, KS and Vasey, FB. (2001) Antinuclear antibody-negative, drug-induced lupus caused by lisinopril <i>South Med J<\/i>, 94, pp. 1122 - 1123.","journal-title":"South Med J"},{"key":"E00091","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.1991.00400080147030","volume":"151","author":"Ahmad S","year":"1991","unstructured":"Ahmad, S. (1991) Lovastatin-induced lupus erythematosus <i>Arch Intern Med<\/i>, 151, pp. 1667 - 2168.","journal-title":"Arch Intern Med"},{"key":"E00092","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.1992.00400170157032","volume":"152","author":"Bannwarth B","year":"1992","unstructured":"Bannwarth, B and Miremont, G and Papapietro, PM. (1992) Lupus-like syndrome associated with simvastatin <i>Arch Intern Med<\/i>, 152, pp. 1093.","journal-title":"Arch Intern Med"},{"key":"E00093","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(98)85019-8","volume":"352","author":"Sridhar MK","year":"1998","unstructured":"Sridhar, MK and Abdulla, A. (1998) Fatal lupus-like syndrome and ARDS induced by fluvastatin <i>Lancet<\/i>, 352, pp. 114.","journal-title":"Lancet"},{"key":"E00094","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(05)60116-X","volume":"352","author":"Hanson J","year":"1998","unstructured":"Hanson, J and Bossingham, D. (1998) Lupus-like syndrome associated with simvastatin <i>Lancet<\/i>, 352, pp. 1070.","journal-title":"Lancet"},{"key":"E00095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/096120330000900715","volume":"9","author":"Sarzi-Puttini P","year":"2000","unstructured":"Sarzi-Puttini, P and Panni, B and Cazzola, M and Muzzupappa, S and Turiel, M. (2000) Lamotrigine-induced lupus <i>Lupus<\/i>, 9, pp. 555 - 557.","journal-title":"Lupus"},{"key":"E00096","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archderm.137.9.1196","volume":"137","author":"Callen JP","year":"2001","unstructured":"Callen, JP and Hughes, AP and Kulp-Shorten, C. (2001) Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: A report of 5 cases <i>Arch Dermatol<\/i>, 137, pp. 1196 - 1198.","journal-title":"Arch Dermatol"},{"key":"E00097","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1067\/mjd.2001.114565","volume":"44","author":"Bonsmann G","year":"2001","unstructured":"Bonsmann, G and Schiller, M and Luger, TA and Stander, S. (2001) Terbinafine-induced subacute cutaneous lupus erythematosus <i>J Am Acad Dermatol<\/i>, 44, pp. 925 - 931.","journal-title":"J Am Acad Dermatol"},{"key":"E00098","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.1998.02194.x","volume":"138","author":"Murphy M","year":"1998","unstructured":"Murphy, M and Barnes, L. (1998) Terbinafine-induced lupus erythematosus <i>Br J Dermatol<\/i>, 138, pp. 708 - 709.","journal-title":"Br J Dermatol"},{"key":"E00099","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1046\/j.1365-2133.1998.2576q.x","volume":"139","author":"Brooke R","year":"1998","unstructured":"Brooke, R and Coulson, IH and al-Dawoud, A. (1998) Terbinafine-induced subacute cutaneous lupus erythematosus <i>Br J Dermatol<\/i>, 139, pp. 1132 - 1133.","journal-title":"Br J Dermatol"},{"key":"E00100","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1046\/j.1365-2133.1998.2576r.x","volume":"139","author":"Holmes S","year":"1998","unstructured":"Holmes, S and Kemmett, D. (1998) Exacerbation of systemic lupus erythematosus induced by terbinafine <i>Br J Dermatol<\/i>, 139, pp. 1133.","journal-title":"Br J Dermatol"},{"key":"E00101","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D30C82J69B","volume":"5","author":"Phillips R","year":"1999","unstructured":"Phillips, R and Nash, M. (1999) Terbinafine and lupus erythematosus a chance association? <i>Dermatol Online J<\/i>, 5, pp. 9.","journal-title":"Dermatol Online J"},{"key":"E00102","first-page":"54","volume":"11","author":"Yoshimasu T","year":"2001","unstructured":"Yoshimasu, T and Hiroi, A and Uede, K and Furukawa, F. (2001) Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT) <i>Eur J Dermatol<\/i>, 11, pp. 54 - 57.","journal-title":"Eur J Dermatol"},{"key":"E00103","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.1978.01640220047012","volume":"114","author":"Horio T","year":"1978","unstructured":"Horio, T and Murai, T and Ikai, K. (1978) Photosensitivity due to a fluorouracil derivative <i>Arch Dermatol<\/i>, 114, pp. 1498 - 1500.","journal-title":"Arch Dermatol"},{"key":"E00104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/berh.2002.0225","volume":"16","author":"Askanase AD","year":"2002","unstructured":"Askanase, AD and Buyon, JP. (2002) Reproductive health in SLE <i>Best Pract Res Clin Rheumatol<\/i>, 16, pp. 265 - 280.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"E00105","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/art.1780371109","volume":"37","author":"Ben-Chetrit A","year":"1994","unstructured":"Ben-Chetrit, A and Ben-Chetrit, E. (1994) Systemic lupus erythematosus induced by ovulation induction treatment <i>Arthritis Rheum<\/i>, 37, pp. 1614 - 1647.","journal-title":"Arthritis Rheum"},{"key":"E00106","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/rheumatology\/38.4.372","volume":"38","author":"Yang LY","year":"1999","unstructured":"Yang, LY and Huang, WJ and Chen, WP and Fu, LW and Lin, CY. (1999) Does parenteral oestrogen therapy flare up disease activity in patients with systemic lupus erythematosus complicated by haemorrhagic cystitis? <i>Rheumatology<\/i>, 38, pp. 372 - 373.","journal-title":"Rheumatology"},{"key":"E00107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/152460901300139989","volume":"10","author":"Greenstein BD","year":"2001","unstructured":"Greenstein, BD. (2001) Lupus: Why women? <i>J Womens Health Gend Based Med<\/i>, 10, pp. 233 - 239.","journal-title":"J Womens Health Gend Based Med"},{"key":"E00108","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0140-6736(01)05731-2","volume":"358","author":"Grant EC","year":"2001","unstructured":"Grant, EC. (2001) Systemic lupus erythematosus <i>Lancet<\/i>, 358, pp. 586.","journal-title":"Lancet"},{"key":"E00109","first-page":"1515","volume":"25","author":"Meier CR","year":"1998","unstructured":"Meier, CR and Sturkenboom, MC and Cohen, AS and Jick, H. (1998) Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus <i>J Rheumatol<\/i>, 25, pp. 1515 - 1519.","journal-title":"J Rheumatol"},{"key":"E00110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339400300104","volume":"3","author":"Arden NK","year":"1994","unstructured":"Arden, NK and Lloyd, ME and Spector, TD and Hughes, GR. (1994) Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE) <i>Lupus<\/i>, 3, pp. 11 - 13.","journal-title":"Lupus"},{"key":"E00111","first-page":"2149","volume":"24","author":"Kreidstein S","year":"1997","unstructured":"Kreidstein, S and Urowitz, MB and Gladman, DD and Gough, J. (1997) Hormone replacement therapy in systemic lupus erythematosus <i>J Rheumatol<\/i>, 24, pp. 2149 - 2152.","journal-title":"J Rheumatol"},{"key":"E00112","doi-asserted-by":"crossref","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"Buyon JP","year":"2005","unstructured":"Buyon, JP and Petri, MA and Kim, MY and (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial <i>Ann Intern Med.<\/i>, 142, pp. 953 - 962.","journal-title":"Ann Intern Med."},{"key":"E00113","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(80)91554-8","volume":"1","author":"Batchelor JR","year":"1980","unstructured":"Batchelor, JR and Welsh, KI and Tinoco, RM and (1980) Hydralazine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility <i>Lancet<\/i>, 1, pp. 1107 - 1109.","journal-title":"Lancet"},{"key":"E00114","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2133.2000.03357.x","volume":"142","author":"Dunphy J","year":"2000","unstructured":"Dunphy, J and Oliver, M and Rands, AL and Lovell, CR and McHugh, NJ. (2000) Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome <i>Br J Dermatol<\/i>, 142, pp. 461 - 467.","journal-title":"Br J Dermatol"},{"key":"E00115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/rheumatology\/36.10.1089","volume":"36","author":"Gunnarsson L","year":"1997","unstructured":"Gunnarsson, L and Kanerud, E and Pettersson and (1997) Predisposing factors in sulphasalazine-induced systemic lupus erythematosus <i>Br J Rheumatol<\/i>, 36, pp. 1089 - 1094.","journal-title":"Br J Rheumatol"},{"key":"E00116","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(89)92506-3","volume":"1","author":"Speirs C","year":"1989","unstructured":"Speirs, C and Fielder, AH and Chapel, H and Davey, NJ and Batchelor, JR. (1989) Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus <i>Lancet<\/i>, 1, pp. 922 - 924.","journal-title":"Lancet"},{"key":"E00117","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(96)03594-9","volume":"119","author":"Uetrecht JP","year":"1997","unstructured":"Uetrecht, JP. (1997) Current trends in drug-induced autoimmunity <i>Toxicology<\/i>, 119, pp. 37 - 43.","journal-title":"Toxicology"}],"updated-by":[{"DOI":"10.1080\/08916930802038194","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"record-id":"1027"}],"container-title":["Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08916930500285857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:47:12Z","timestamp":1706824032000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08916930500285857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":117,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,7,7]]},"published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1080\/08916930500285857"],"URL":"https:\/\/doi.org\/10.1080\/08916930500285857","relation":{},"ISSN":["0891-6934","1607-842X"],"issn-type":[{"value":"0891-6934","type":"print"},{"value":"1607-842X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}